INR 2459.15
(1.23%)
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2023 | 908.84 Million INR | -42.73% |
2022 | 1.58 Billion INR | 44.69% |
2021 | 1.09 Billion INR | 10.59% |
2020 | 991.79 Million INR | 12.79% |
2019 | 879.36 Million INR | 39.17% |
2018 | 631.86 Million INR | 19.31% |
2017 | 529.58 Million INR | -8.88% |
2016 | 581.22 Million INR | 8.92% |
2015 | 533.6 Million INR | 58.9% |
2014 | 335.81 Million INR | 26.04% |
2013 | 266.43 Million INR | 16.6% |
2012 | 228.5 Million INR | 31.7% |
2011 | 173.49 Million INR | 63.72% |
2010 | 105.96 Million INR | 6.03% |
2009 | 99.93 Million INR | 24.77% |
2008 | 80.1 Million INR | -10.15% |
2007 | 89.14 Million INR | 163.53% |
2006 | 33.82 Million INR | 0.0% |
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2024 Q1 | 251.81 Million INR | -1.98% |
2024 Q2 | 442.16 Million INR | -4.21% |
2023 Q1 | 447.18 Million INR | 14.45% |
2023 FY | 908.84 Million INR | -42.73% |
2023 Q4 | 256.89 Million INR | -35.68% |
2023 Q3 | 399.38 Million INR | -4.9% |
2023 Q2 | 419.98 Million INR | -6.08% |
2022 FY | 1.58 Billion INR | 44.69% |
2022 Q1 | 339.69 Million INR | 103.81% |
2022 Q2 | 440.44 Million INR | 29.66% |
2022 Q4 | 390.71 Million INR | -6.1% |
2022 Q3 | 416.07 Million INR | -5.53% |
2021 Q4 | 166.67 Million INR | -48.75% |
2021 Q3 | 325.21 Million INR | 1.62% |
2021 Q2 | 320.03 Million INR | 12.34% |
2021 Q1 | 284.87 Million INR | 37.05% |
2021 FY | 1.09 Billion INR | 10.59% |
2020 Q1 | 261.67 Million INR | 651.9% |
2020 Q3 | 253.06 Million INR | -6.0% |
2020 Q4 | 207.86 Million INR | -17.86% |
2020 Q2 | 269.2 Million INR | 2.88% |
2020 FY | 991.79 Million INR | 12.79% |
2019 Q4 | 34.8 Million INR | -87.44% |
2019 FY | 879.36 Million INR | 39.17% |
2019 Q1 | 248.37 Million INR | 547.24% |
2019 Q2 | 307.95 Million INR | 23.99% |
2019 Q3 | 277.12 Million INR | -10.01% |
2018 Q1 | 215.19 Million INR | 0.0% |
2018 FY | 631.86 Million INR | 19.31% |
2018 Q4 | -55.53 Million INR | -126.3% |
2018 Q3 | 211.17 Million INR | -19.1% |
2018 Q2 | 261.04 Million INR | 21.31% |
2017 FY | 529.58 Million INR | -8.88% |
2016 FY | 581.22 Million INR | 8.92% |
2015 FY | 533.6 Million INR | 58.9% |
2014 FY | 335.81 Million INR | 26.04% |
2013 FY | 266.43 Million INR | 16.6% |
2012 Q3 | 60.28 Million INR | 20.66% |
2012 Q1 | 47.75 Million INR | 0.0% |
2012 FY | 228.5 Million INR | 31.7% |
2012 Q4 | 70.51 Million INR | 16.97% |
2012 Q2 | 49.96 Million INR | 4.63% |
2011 FY | 173.49 Million INR | 63.72% |
2010 FY | 105.96 Million INR | 6.03% |
2009 FY | 99.93 Million INR | 24.77% |
2008 FY | 80.1 Million INR | -10.15% |
2007 FY | 89.14 Million INR | 163.53% |
2006 FY | 33.82 Million INR | 0.0% |
Name | Operating Expenses | Operating Expenses Difference |
---|---|---|
Sigachi Industries Limited | 579.88 Million INR | -56.727% |
Ind-Swift Limited | 946.56 Million INR | 3.986% |
Bajaj HealthCare Limited | 985.34 Million INR | 7.764% |
Sakar Healthcare Limited | 204.07 Million INR | -345.337% |
Aurobindo Pharma Limited | 55.65 Billion INR | 98.367% |
Innova Captab Limited | 931.03 Million INR | 2.383% |
Divi's Laboratories Limited | 14.17 Billion INR | 93.586% |
AstraZeneca Pharma India Limited | 2.47 Billion INR | 63.257% |
Morepen Laboratories Limited | 1.98 Billion INR | 54.271% |
Mankind Pharma Limited | 29.27 Billion INR | 96.895% |
Sequent Scientific Limited | 2.9 Billion INR | 68.68% |
Wanbury Limited | 978.96 Million INR | 7.163% |
Laurus Labs Limited | 11.9 Billion INR | 92.369% |
Nectar Lifesciences Limited | 932.7 Million INR | 2.558% |
Glenmark Life Sciences Limited | 11.64 Billion INR | 92.193% |
Alembic Limited | 872.45 Million INR | -4.17% |
Hikal Limited | 4.46 Billion INR | 79.64% |
Alembic Pharmaceuticals Limited | 15.86 Billion INR | 94.273% |
Neuland Laboratories Limited | 2.92 Billion INR | 68.979% |
J. B. Chemicals & Pharmaceuticals Limited | 14.79 Billion INR | 93.856% |
Glenmark Pharmaceuticals Limited | 46.95 Billion INR | 98.064% |
IOL Chemicals and Pharmaceuticals Limited | 2.2 Billion INR | 58.708% |
Themis Medicare Limited | 1.12 Billion INR | 19.271% |
RPG Life Sciences Limited | 1.63 Billion INR | 44.43% |
Zydus Lifesciences Limited | 125.21 Billion INR | 99.274% |
Lupin Limited | 125.09 Billion INR | 99.273% |
Amrutanjan Health Care Limited | 2.09 Billion INR | 56.599% |
Wockhardt Limited | 8.48 Billion INR | 89.283% |
Vaishali Pharma Limited | 84.02 Million INR | -981.579% |
Aarti Pharmalabs Limited | 3.07 Billion INR | 70.438% |
Jagsonpal Pharmaceuticals Limited | 438.55 Million INR | -107.237% |
Jubilant Pharmova Limited | 14.45 Billion INR | 93.712% |
FDC Limited | 3.49 Billion INR | 74.031% |
Dr. Reddy's Laboratories Limited | 95.87 Billion INR | 99.052% |
Kilitch Drugs (India) Limited | 412.42 Million INR | -120.364% |
Eris Lifesciences Limited | 4.94 Billion INR | 81.613% |
Venus Remedies Limited | 1.91 Billion INR | 52.573% |
ZIM Laboratories Limited | 1.01 Billion INR | 10.287% |
Bliss GVS Pharma Limited | 1.41 Billion INR | 35.962% |
Par Drugs and Chemicals Limited | 58.28 Million INR | -1459.223% |
Caplin Point Laboratories Limited | 2.17 Billion INR | 58.205% |
Shilpa Medicare Limited | 3.33 Billion INR | 72.742% |
Albert David Limited | 1.02 Billion INR | 11.432% |
Ajanta Pharma Limited | 30.46 Billion INR | 97.017% |
Suven Pharmaceuticals Limited | 1.4 Billion INR | 35.212% |
Solara Active Pharma Sciences Limited | 2.55 Billion INR | 64.416% |
Gufic Biosciences Limited | 1.18 Billion INR | 23.407% |
Windlas Biotech Limited | 1 Billion INR | 9.704% |
Procter & Gamble Health Limited | 2.99 Billion INR | 69.659% |
Aarey Drugs & Pharmaceuticals Limited | 14.21 Million INR | -6294.428% |
Mangalam Drugs & Organics Limited | 162.22 Million INR | -460.224% |
Granules India Limited | 10.31 Billion INR | 91.187% |
Aarti Drugs Limited | 1.16 Billion INR | 22.154% |
Bal Pharma Limited | 555.62 Million INR | -63.57% |
Alkem Laboratories Limited | 32.83 Billion INR | 97.232% |
Sun Pharmaceutical Industries Limited | 154.18 Billion INR | 99.411% |
Lincoln Pharmaceuticals Limited | 1.07 Billion INR | 15.393% |
Medicamen Biotech Limited | 335.16 Million INR | -171.16% |
Unichem Laboratories Limited | 6.72 Billion INR | 86.487% |
Bafna Pharmaceuticals Limited | 455.58 Million INR | -99.489% |
Biofil Chemicals and Pharmaceuticals Limited | 6.82 Million INR | -13226.1% |
Valiant Laboratories Limited | 138.02 Million INR | -558.441% |
Orchid Pharma Limited | 800.77 Million INR | -13.496% |
Medico Remedies Limited | 59.67 Million INR | -1422.983% |
Ind-Swift Laboratories Limited | 2.12 Billion INR | 57.215% |
Ipca Laboratories Limited | 18.98 Billion INR | 95.214% |
Brooks Laboratories Limited | 51.18 Million INR | -1675.772% |
Syncom Formulations (India) Limited | 345.63 Million INR | -162.949% |
Piramal Enterprises Limited | 63.65 Billion INR | 98.572% |
Torrent Pharmaceuticals Limited | 21.42 Billion INR | 95.757% |
NATCO Pharma Limited | 10.05 Billion INR | 90.964% |
Suven Life Sciences Limited | 109.75 Million INR | -728.1% |
Krebs Biochemicals & Industries Limited | 46.15 Million INR | -1869.061% |
Strides Pharma Science Limited | 9.16 Billion INR | 90.081% |
Indoco Remedies Limited | 12.06 Billion INR | 92.465% |
Alpa Laboratories Limited | 127.38 Million INR | -613.487% |
Lasa Supergenerics Limited | 291.17 Million INR | -212.13% |
Sun Pharma Advanced Research Company Limited | 3.07 Billion INR | 70.462% |